Albert Bourla, chief executive officer of Pfizer, speaks at a news conference at the 51st annual meeting of the World Economic Forum in Davos, Switzerland, on May 25, 2022. Pfizer announced that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world’s poorest countries.
The drugmaker announced the program at the World Economic Forum’s annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. Most of the countries are in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea.The products, which are widely available in the U.S. and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions.
“What we discovered through the pandemic was that supply was not enough to resolve the issues that these countries are having,” Pfizer Chairman and CEO Albert Bourla said Wednesday during a talk at Davos. Earlier this month, the head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries.
i thought there was going to be a vaccine shortage in the US….
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer to Offer Low-Cost Medicines, Vaccines to 45 Lower-Income NationsA company spokeswoman says only a small number of the medicines and vaccines are currently available in those countries.
Source: nbcchicago - 🏆 545. / 51 Read more »
Pfizer Says Their COVID-19 Vaccine For Kids Under 5 Is 80% Effective Against OmicronPfizer said in preliminary findings in a subset of a clinical trial indicate that 3 doses of the vaccine are 80% effective in preventing symptomatic infection.
Source: ScaryMommy - 🏆 116. / 63 Read more »
Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5Drugmakers Pfizer and BioNTech said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial. you mean to your bank account 🤦♀️ Great news but can Pfizer keep up with Moderna’s technology advantage? Nasty company 😡
Source: Reuters - 🏆 2. / 97 Read more »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company said Monday, another step toward shots for the littlest kids possibly beginning in early summer.
Source: adndotcom - 🏆 293. / 63 Read more »
Pfizer says 3 COVID shots protect children under 5Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week. Monkeypox is the new thing you’re supposed to be scaring people about. Try to keep up. They also die from colds and flu… while that is incredibly sad, they don’t push experimental drugs, that have has high number of unexplained deaths tied to them… are you seriously peddling for big pharma?
Source: AKNewsNow - 🏆 460. / 53 Read more »
Pfizer: 3 COVID vaccine doses are 80 percent effective for kids 5 and underThree doses of the Pfizer-BioNTech COVID-19 vaccine were roughly 80 percent effective at preventing infections for children ages 6 months to 5 years old, according to trial data Pfizer released Monday. Why stop at 3? Why not 4, 5, 6?
Source: KPIXtv - 🏆 443. / 53 Read more »